Tuberculin test measurement at 48 and 72 hours: mismatch and clinical significance.

Elena Yela, Lidia Puig, Mireia De Odriozola, ��ngels Flores-Imbernon, Nerea Girado, Adri�� Jacas, Mireia Llopart, Carmen Mac��as, S��nia Mellado, X��nia Rue, Pilar S��nchez-Encomienda, Maite Serrats, Jordi Tost, Elisabet Turu
Author Information
  1. Elena Yela: Sant Esteve Sesrovires 1 Prison Primary Healthcare Team. Metropolitana Sud Primary Healthcare Department, Catalan Health Institute.
  2. Lidia Puig: Sant Esteve Sesrovires 1 Prison Primary Healthcare Team. Metropolitana Sud Primary Healthcare Department, Catalan Health Institute.
  3. Mireia De Odriozola: Sant Esteve Sesrovires 1 Prison Primary Healthcare Team. Metropolitana Sud Primary Healthcare Department, Catalan Health Institute.
  4. ��ngels Flores-Imbernon: Sant Esteve Sesrovires 1 Prison Primary Healthcare Team. Metropolitana Sud Primary Healthcare Department, Catalan Health Institute.
  5. Nerea Girado: Sant Esteve Sesrovires 1 Prison Primary Healthcare Team. Metropolitana Sud Primary Healthcare Department, Catalan Health Institute.
  6. Adri�� Jacas: Sant Esteve Sesrovires 1 Prison Primary Healthcare Team. Metropolitana Sud Primary Healthcare Department, Catalan Health Institute.
  7. Mireia Llopart: Sant Esteve Sesrovires 1 Prison Primary Healthcare Team. Metropolitana Sud Primary Healthcare Department, Catalan Health Institute.
  8. Carmen Mac��as: Sant Esteve Sesrovires 1 Prison Primary Healthcare Team. Metropolitana Sud Primary Healthcare Department, Catalan Health Institute.
  9. S��nia Mellado: Sant Esteve Sesrovires 1 Prison Primary Healthcare Team. Metropolitana Sud Primary Healthcare Department, Catalan Health Institute.
  10. X��nia Rue: Sant Esteve Sesrovires 1 Prison Primary Healthcare Team. Metropolitana Sud Primary Healthcare Department, Catalan Health Institute.
  11. Pilar S��nchez-Encomienda: Sant Esteve Sesrovires 1 Prison Primary Healthcare Team. Metropolitana Sud Primary Healthcare Department, Catalan Health Institute.
  12. Maite Serrats: Sant Esteve Sesrovires 1 Prison Primary Healthcare Team. Metropolitana Sud Primary Healthcare Department, Catalan Health Institute.
  13. Jordi Tost: Sant Esteve Sesrovires 1 Prison Primary Healthcare Team. Metropolitana Sud Primary Healthcare Department, Catalan Health Institute.
  14. Elisabet Turu: Prison Health Programme, Healthcare Department of the Catalan Health Institute.

Abstract

OBJECTIVE: To measure Tuberculin Skin Test (TST) at 48 and 72 hours and, if there are differences, to determine the concordance and whether it is of clinical significance (change in the TST score).
MATERIAL AND METHOD: Prospective study of those admitted to prison between March and June 2023, screened by means of TST read at 48 and 72 hours by trained personnel, assessed according to criteria in force in Spain. When the measurement varied, concordance was checked using the kappa index (() and its clinical significance. To determine variables associated with clinical significance, bivariate and multivariate analysis was performed using logistic regression.
RESULTS: 488 cases were studied. TST was positive in 20.1, 23.4 and 23.8% at 48 hours, 72 hours or any of them, respectively. There was more TST positive in foreigners or BCG vaccinated. The reading varied in 35.2% (mean deviation 5.5 +/-4.4 mm) and was higher at 72 hours (86% of different cases). Inter-reading concordance was excellent overall (( = 0.892) and in BCG vaccinated (( = 0.805), but moderate in immunocompromised (( = 0.421). Discordance was clinically significant in 3.7% and was not associated with any variable.
DISCUSSION: TST concordance at 48-72 hours is excellent, but in some patients (3.7% in this work) the score is incorrect, more so in readings at 48 hours. The proportion is low, but can be reduced if the reading is taken at 72 hours and Interferon Gamma Release Assay tests are used in some cases (immunocompromised, etc.).

References

  1. Semin Respir Infect. 1989 Sep;4(3):182-8 [PMID: 2688001]
  2. Arch Intern Med. 1988 Nov;148(11):2457-9 [PMID: 3190377]
  3. Clin Infect Dis. 2005 Jan 15;40(2):246-50 [PMID: 15655742]
  4. Chest. 2002 Oct;122(4):1299-301 [PMID: 12377856]
  5. Int J Tuberc Lung Dis. 2022 Sep 1;26(9):857-861 [PMID: 35996296]
  6. Cad Saude Publica. 2021 Aug 30;37(8):e00027321 [PMID: 34495087]
  7. Int J Tuberc Lung Dis. 2013 Oct;17(10):1273-8 [PMID: 24025377]
  8. Biometrics. 1977 Mar;33(1):159-74 [PMID: 843571]
  9. Aten Primaria. 1996 Feb 15;17(2):173 [PMID: 8948763]
  10. Lancet Glob Health. 2019 Apr;7(4):e396-e397 [PMID: 30824365]
  11. Am J Respir Crit Care Med. 2014 Nov 15;190(10):1168-76 [PMID: 25303140]
  12. Eur Respir J. 2015 Dec;46(6):1563-76 [PMID: 26405286]
  13. J Infect Dev Ctries. 2018 Aug 31;12(8):625-630 [PMID: 31958324]

MeSH Term

Humans
Tuberculin Test
Prospective Studies
Male
Female
Adult
Time Factors
Middle Aged
Spain
Tuberculosis
Prisoners
Young Adult
BCG Vaccine
Clinical Relevance

Chemicals

BCG Vaccine

Word Cloud

Created with Highcharts 10.0.0hoursTST7248concordanceclinicalsignificancecases=0Tuberculindeterminescoremeasurementvariedusingassociatedpositive234BCGvaccinatedreading5excellentimmunocompromised37%OBJECTIVE:measureSkinTestdifferenceswhetherchangeMATERIALANDMETHOD:ProspectivestudyadmittedprisonMarchJune2023screenedmeansreadtrainedpersonnelassessedaccordingcriteriaforceSpaincheckedkappaindexvariablesbivariatemultivariateanalysisperformedlogisticregressionRESULTS:488studied2018%respectivelyforeigners352%meandeviation+/-4mmhigher86%differentInter-readingoverall892805moderate421DiscordanceclinicallysignificantvariableDISCUSSION:48-72patientsworkincorrectreadingsproportionlowcanreducedtakenInterferonGammaReleaseAssaytestsusedetctesthours:mismatch

Similar Articles

Cited By